Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Operating Expenses: 2011-2024

Historic Operating Expenses for Tenax Therapeutics (TENX) over the last 11 years, with Dec 2024 value amounting to $19.5 million.

  • Tenax Therapeutics' Operating Expenses was N/A to $42.2 million in Q4 2016 from the same period last year, while for Dec 2016 it was $58.6 million, marking a year-over-year change of. This contributed to the annual value of $19.5 million for FY2024, which is 136.75% up from last year.
  • Tenax Therapeutics' Operating Expenses amounted to $19.5 million in FY2024, which was up 136.75% from $8.2 million recorded in FY2023.
  • Tenax Therapeutics' Operating Expenses' 5-year high stood at $19.5 million during FY2024, with a 5-year trough of $8.2 million in FY2023.
  • Moreover, its 3-year median value for Operating Expenses was $11.1 million (2022), whereas its average is $12.9 million.
  • In the last 5 years, Tenax Therapeutics' Operating Expenses decreased by 25.50% in 2023 and then skyrocketed by 136.75% in 2024.
  • Over the past 4 years, Tenax Therapeutics' Operating Expenses (Yearly) stood at $9.9 million in 2020, then reached $11.1 million in 2022, then declined by 25.50% to $8.2 million in 2023, then skyrocketed by 136.75% to $19.5 million in 2024.